Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Efficacy of Topical Triple Regimen Versus 30% Metformin in the Treatment of Epidermal Melasma

NCT07779811 is registered in ClinicalTrials.gov with Combined Military Hospital, Pakistan as lead sponsor.

NCT NCT07779811
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07779811 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Efficacy of Topical Triple Regimen Versus 30% Metformin in the Treatment of Epidermal Melasma
Lead sponsor
Combined Military Hospital, Pakistan
Phase
Phase 2
Overall status
Not yet recruiting
Start date
August 15, 2026
Completion date
January 30, 2027
Enrollment
104 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epidermal melasma, facial hyperpigmentation